1. Longer‐term liraglutide administration at the highest dose approved for obesity increases reward‐related orbitofrontal cortex activation in response to food cues: Implications for plateauing weight loss in response to anti‐obesity therapies. Issue 11 (8th August 2019) Authors: Farr, Olivia M.; Upadhyay, Jagriti; Rutagengwa, Chelsea; DiPrisco, Bridget; Ranta, Zachary; Adra, Amal; Bapatla, Neha; Douglas, Vivian P.; Douglas, Konstantinos A. A.; Nolen‐Doerr, Eric; Mathew, Hannah; Mantzoros, Christos S. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 11(2019) Page Start: 2459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗